BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Caranx Medical Announces First Clinical Use of the TAVIPILOT Soft, Cleared by FDA for Commercial in July

  November 18, 2025

   · 

  4 min read
• Press Releases

  OCEAN Dx Rapid Diagnostic Test for Sepsis Matched Gold Standard During a Clinical Evaluation Study

  November 18, 2025

   · 

  2 min read
• Press Releases

  ChristianaCare Gene Editing Institute Achieves CRISPR Breakthrough That Reverses Chemotherapy Resistance in Lung Cancer

  November 18, 2025

   · 

  4 min read
• Press Releases

  Arctx Medical Receives FDA Marketing Authorization for its Arctx Cool Catheter™ Set for Body Temperature Regulation, Releases Initial Clinical Results in Acute Pancreatitis

  November 18, 2025

   · 

  4 min read
• Press Releases

  CorriXR Therapeutics Announces Publication of Preclinical Data Demonstrating Potential of CRISPR-Directed Gene Editing to Overcome Drug Resistance in Solid Tumors

  November 18, 2025

   · 

  4 min read
• Press Releases

  Ankyra Therapeutics Announces First Patient Dosed in Phase 1b Trial Evaluating First-in-Class Anchored Immunotherapy in Combination with Immune Checkpoint Blockade in Patients with Lung Cancer

  November 18, 2025

   · 

  3 min read
• Press Releases

  Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer

  November 18, 2025

   · 

  4 min read
• Press Releases

  Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open

  November 18, 2025

   · 

  6 min read
• Press Releases

  Naveris Announces Expanded Medicare Coverage for the NavDx® Test in Identification of Molecular Residual Disease of Anal Squamous Cell Carcinoma

  November 18, 2025

   · 

  4 min read
• Press Releases

  PRV111, in Development as the First Non-Surgical Therapy for Early-Stage Non-Invasive Oral Cancer and High-Grade Dysplasias, Meets Its Primary Efficacy Endpoint in Ongoing Phase 2/3 Trial

  November 18, 2025

   · 

  4 min read